🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Intracranial Arteriosclerosis

Making Connections Thru Music NCT06079216NA2 sites📍 Winchester📍 Winchester Hopeful Aging · Tests: Volunteer Led Making Connections Thru Music, Staff Led Making Connections Thru Music Retinal Hyperspectral Imaging in Neurodegenerative Diseases NCT07545473NA1 site📍 Melbourne Center for Eye Research Australia · Tests: Hyperspectral camera Association of Transcranial Alternating Current Stimulation with Digital Cognitive Training for Cognitive Remediation in Older Adults NCT06733714NA1 site📍 Rio de Janeiro Universidade Federal do Rio de Janeiro · Tests: Transcranial Alternating Current Stimulation, Digital Cognitive Training Taiwan Post-Stroke Disability Study NCT06772194n/a1 site📍 Taipei National Taiwan University Hospital Coexistence of Cerebral and Coronary Atherosclerosis in Acute Ischemic Cerebrovascular Disease Patients Registry NCT03788512n/a1 site📍 Beijing Xuanwu Hospital, Beijing · Tests: observational only- no intervention The Imperial Comprehensive Cognitive Assessment in Cerebrovascular Disease (IC3) NCT05885295n/a1 site📍 London Imperial College London · Tests: MRI brain, Blood tests, cognitive assessments Pulsed Electromagnetic Field Treatment With Dementia Patients NCT06862557NA1 site📍 Boca Raton Herrick Medical LLC · Tests: ECHS AD Device Predictors of Emergency Department Use in Frail Patients NCT07259499n/a1 site📍 Pisa University of Pisa · Tests: Plasma phosphorylated Tau 181 Digital Secondary Prevention After Atherosclerotic Cardiovascular Disease NCT06738381NA1 site📍 Drammen Vestre Viken Hospital Trust · Tests: Digital intervention and motivational counselling Cognitive Decline and Underlying Mechanisms in Symptomatic Intracranial Artery Stenosis Patients: A Cohort Study NCT06336174n/a1 site📍 Hefei Anhui Medical University · Tests: Aspirin Tablet, Clopidogrel Bisulfate Tablets and Atorvastatin, Endovascular therapy,Aspirin Tablet, Clopidogrel Bisulf… The Effect of InTensive Statin in Ischemic Stroke With inTracranial Atherosclerotic Plaques NCT03753555Phase 41 site📍 Shenyang General Hospital of Shenyang Military Region · Tests: Atorvastatin Calcium, Atorvastatin Calcium, Probucol, PCSK9 inhibitor DC Longitudinal Study on Aging and Specimen Bank NCT03702907n/a1 site📍 Washington D.C. Georgetown University Natives Engaged in Alzheimers Research - 'Ike Kupuna NCT05534607NA3 sites📍 Honolulu📍 Honolulu📍 Wailuku University of Hawaii · Tests: Ola Mau i ka Hula Multidimensional Rehabilitation Programs for Cognitive Impairment in Comorbid Outpatients: a Randomized Controlled Trial NCT05954741NA1 site📍 Montescano Istituti Clinici Scientifici Maugeri SpA · Tests: Motor rehabilitation alone, Motor rehabilitation and Cognitive rehabilitation (paper-based), Motor rehabilitation and c… The Swedish BioFINDER - Memory Clinic Study NCT06122415n/a1 site📍 Malmö Skane University Hospital · Tests: Plasma Amyloid Probability Score 2 (APS 2) score, Plasma ptau217/nptau217, Plasma ptau217, Plasma neurofilament light (… Feedback Loop Between Intracranial Atherosclerosis and Cerebral Small Vessel Disease NCT05677607n/a1 site📍 Beijing Chinese PLA General Hospital · Tests: Magnetic resonance imaging PUMCH Dementia Longitudinal Cohort Study NCT05023564n/a1 site📍 Beijing Peking Union Medical College Hospital ICAS Screen Based on RIC NCT06610578n/a1 site📍 Beijing Xuanwu Hospital, Beijing · Tests: fundus imaging Product Surveillance Registry NCT01524276n/a402 sites📍 Birmingham📍 Huntsville📍 Chandler Medtronic A Registry Study of Intracranial Atherosclerotic Stenosis Treatment by Intracranial Drug-eluting Stenting in China NCT05692882NA5 sites📍 Chenzhou📍 Ganzhou📍 Jinhua Sino Medical Sciences Technology Inc. · Tests: Drug-Eluting Stents MPR for Stroke Risk Assessment of ICAS NCT07309718n/a1 site📍 Beijing Xuanwu Hospital, Beijing · Tests: Standardized medical therapy targeting vascular risk factors and stroke prevention Coated or Chewable Aspirin and a Hybrid Strategy to Mitigate Adverse Effects of Air Pollution in Stable Atherosclerotic Disease NCT06541691NA1 site📍 Tehran Rajaie Cardiovascular Medical and Research Center · Tests: Enteric-coated aspirin, Plain aspirin, Hybrid strategy Imaging of Intracranial and Extracranial Arterial Atherosclerotic Plaques Using Different Field Strength MRIs NCT06754956NA1 site📍 Shanghai Shanghai Jiao Tong University Affiliated Sixth People's Hos… · Tests: The patient will receive two intravenous injections of the same gadoterate meglumine contrast agent. The Swedish BioFINDER - Primary Care Study NCT06120361n/a1 site📍 Malmö Skane University Hospital · Tests: Plasma APS 2 score, Plasma p-tau217/np-tau217, Plasma p-tau217, Plasma neurofilament light (NfL), Plasma Ab42/Ab40 ENhancing Outcomes in Cognitive Impairment Through Use of Home Sleep ApNea Testing NCT04335994NA1 site📍 Toronto Sunnybrook Health Sciences Centre · Tests: In-laboratory polysomnography, Home Sleep Apnea Test PCSK9 Inhibitor With Statin Therapy for Asymptomatic Intracranial Atherosclerosis NCT06902740Phase 419 sites📍 Beijing📍 Beijing📍 Meizhou Peking Union Medical College Hospital · Tests: Recaticimab and Statin, Statin Drug Eluting Stenting and Aggressive Medical Treatment for Preventing Recurrent Stroke in Intracranial Atherosclerotic Disease Trial NCT04948749NA18 sites📍 Beijing📍 Beijing📍 Cangzhou Beijing Tiantan Hospital · Tests: Drug Eluting Stent implantation, Aggressive medical treatment, Risk factor management, Standard medical treatment Role of GLP1 RA Dulaglutide on Severe Intracranial Atherosclerosis NCT07282041Phase 2, Phase 31 site📍 Singapore National University of Singapore · Tests: Dulaglutide Rifaximin SSD in Dementia Trial NCT06718686Phase 1, Phase 21 site📍 Richmond Jasmohan Bajaj · Tests: Rifaximin SSD 40 mg IR tablet, Placebo Improving Prognostic Confidence in Neurodegenerative Diseases Causing Dementia Using Peripheral Biomarkers and Integrative Modeling NCT06529744n/a4 sites📍 North York📍 Toronto📍 Toronto University Health Network, Toronto
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy